Cost or price of sequencing? Implications for economic evaluations in genomic medicine
Genet Med
.
2021 Oct;23(10):1833-1835.
doi: 10.1038/s41436-021-01223-9.
Epub 2021 Jun 10.
Authors
Scott D Grosse
1
,
James M Gudgeon
2
Affiliations
1
National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, GA, USA. SGG4@CDC.GOV.
2
Intermountain Healthcare Precision Genomics, Salt Lake City, UT, USA.
PMID:
34113006
PMCID:
PMC8487947
DOI:
10.1038/s41436-021-01223-9
No abstract available
Publication types
Research Support, U.S. Gov't, P.H.S.
MeSH terms
Cost-Benefit Analysis
Evidence-Based Medicine*
Genomics*
Humans
Grants and funding
CC999999/ImCDC/Intramural CDC HHS/United States